Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial

This secondary analysis of a randomized clinical trial examines the effect of androgen deprivation therapy (ADT) during radiotherapy in patients who were classified as having either favorable intermediate-risk or unfavorable intermediate-risk prostate cancer.

Detalles Bibliográficos
Autores principales: Zumsteg, Zachary S., Spratt, Daniel E., Daskivich, Timothy J., Tighiouart, Mourad, Luu, Michael, Rodgers, Joseph P., Sandler, Howard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489808/
https://www.ncbi.nlm.nih.gov/pubmed/32902647
http://dx.doi.org/10.1001/jamanetworkopen.2020.15083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489808/
https://www.ncbi.nlm.nih.gov/pubmed/32902647
http://dx.doi.org/10.1001/jamanetworkopen.2020.15083

Ejemplares similares